tiprankstipranks
Avenue Therapeutics (ATXI)
:ATXI
US Market
Holding ATXI?
Track your performance easily

Avenue Therapeutics (ATXI) Dividend Date & History

317 Followers
Avenue Therapeutics (ATXI) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
MO
Altria Group
$3.998 (7.82%)
$86.71B
8.64
28.24%
4 Buy
2 Hold
2 Sell
Hold
T
AT&T
$1.108 (5.04%)
$158.00B
17.90
35.91%
16 Buy
3 Hold
0 Sell
Strong Buy
XRX
Xerox
$1 (11.11%)
$1.12B
-0.85
-41.03%
0 Buy
1 Hold
2 Sell
Moderate Sell
IBM
International Business Machines
$6.666 (3%)
$205.88B
32.41
34.73%
4 Buy
6 Hold
1 Sell
Moderate Buy
CVX
Chevron
$6.52 (4.09%)
$286.42B
17.54
13.86%
16 Buy
3 Hold
0 Sell
Strong Buy
EOG
EOG Resources
$3.705 (3.72%)
$77.65B
11.11
24.06%
11 Buy
12 Hold
0 Sell
Moderate Buy
ET
Energy Transfer
$1.272 (6.3%)
$69.33B
14.90
47.89%
9 Buy
1 Hold
0 Sell
Strong Buy
HESM
Hess Midstream Partners
$2.636 (6.55%)
$8.79B
17.06
27.56%
1 Buy
1 Hold
0 Sell
Moderate Buy
ARCC
Ares Capital
$1.916 (8.35%)
$14.86B
8.83
14.30%
9 Buy
2 Hold
0 Sell
Strong Buy

FAQ

Does Avenue Therapeutics pay dividends?
No, Avenue Therapeutics (ATXI) has not paid a dividend within the past 12 months.
    How much is Avenue Therapeutics's dividend?
    Avenue Therapeutics (ATXI) does not pay a dividend
    When is Avenue Therapeutics ex-dividend date?
    Avenue Therapeutics (ATXI) does not pay a dividend.
    When is Avenue Therapeutics dividend payment date?
    Avenue Therapeutics (ATXI) does not pay a dividend.
    Does Avenue Therapeutics have sufficient earnings to cover their dividend?
    The Avenue Therapeutics has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis